vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and INTERGROUP CORP (INTG). Click either name above to swap in a different company.
AGIOS PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($20.0M vs $17.3M, roughly 1.2× INTERGROUP CORP). INTERGROUP CORP runs the higher net margin — 8.8% vs -541.1%, a 549.8% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs 19.8%). INTERGROUP CORP produced more free cash flow last quarter ($-481.0K vs $-97.3M). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 7.8%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.
AGIO vs INTG — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $17.3M |
| Net Profit | $-108.0M | $1.5M |
| Gross Margin | 90.6% | — |
| Operating Margin | -608.9% | 11.6% |
| Net Margin | -541.1% | 8.8% |
| Revenue YoY | 86.1% | 19.8% |
| Net Profit YoY | -11.9% | 155.6% |
| EPS (diluted) | $-1.86 | $0.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $17.3M | ||
| Q3 25 | $12.9M | $17.9M | ||
| Q2 25 | $12.5M | $16.2M | ||
| Q1 25 | $8.7M | $16.8M | ||
| Q4 24 | $10.7M | $14.4M | ||
| Q3 24 | $9.0M | $16.9M | ||
| Q2 24 | $8.6M | $13.4M | ||
| Q1 24 | $8.2M | $14.9M |
| Q4 25 | $-108.0M | $1.5M | ||
| Q3 25 | $-103.4M | $-535.0K | ||
| Q2 25 | $-112.0M | $-2.2M | ||
| Q1 25 | $-89.3M | $-578.0K | ||
| Q4 24 | $-96.5M | $-2.7M | ||
| Q3 24 | $947.9M | $-398.0K | ||
| Q2 24 | $-96.1M | $-4.9M | ||
| Q1 24 | $-81.5M | $-3.2M |
| Q4 25 | 90.6% | — | ||
| Q3 25 | 87.0% | — | ||
| Q2 25 | 86.3% | — | ||
| Q1 25 | 87.6% | — | ||
| Q4 24 | 88.3% | — | ||
| Q3 24 | 91.3% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 92.3% | — |
| Q4 25 | -608.9% | 11.6% | ||
| Q3 25 | -907.4% | 15.3% | ||
| Q2 25 | -1020.1% | 8.1% | ||
| Q1 25 | -1222.0% | 14.0% | ||
| Q4 24 | -1165.3% | 5.9% | ||
| Q3 24 | -1146.9% | 18.5% | ||
| Q2 24 | -1228.3% | 3.7% | ||
| Q1 24 | -1124.3% | 4.8% |
| Q4 25 | -541.1% | 8.8% | ||
| Q3 25 | -803.1% | -3.0% | ||
| Q2 25 | -899.4% | -13.9% | ||
| Q1 25 | -1023.3% | -3.4% | ||
| Q4 24 | -899.6% | -18.9% | ||
| Q3 24 | 10574.7% | -2.4% | ||
| Q2 24 | -1115.7% | -36.7% | ||
| Q1 24 | -995.8% | -21.3% |
| Q4 25 | $-1.86 | $0.71 | ||
| Q3 25 | $-1.78 | $-0.25 | ||
| Q2 25 | $-1.93 | — | ||
| Q1 25 | $-1.55 | $-0.27 | ||
| Q4 24 | $-1.44 | $-1.26 | ||
| Q3 24 | $16.22 | $-0.18 | ||
| Q2 24 | $-1.69 | — | ||
| Q1 24 | $-1.45 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | $7.5M |
| Total DebtLower is stronger | — | $233.2M |
| Stockholders' EquityBook value | $1.2B | $-85.2M |
| Total Assets | $1.3B | $101.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | $7.5M | ||
| Q3 25 | $92.7M | $6.0M | ||
| Q2 25 | $80.9M | $6.1M | ||
| Q1 25 | $79.0M | $4.8M | ||
| Q4 24 | $76.2M | $15.4M | ||
| Q3 24 | $253.7M | $12.2M | ||
| Q2 24 | $84.5M | $11.6M | ||
| Q1 24 | $118.8M | $19.5M |
| Q4 25 | — | $233.2M | ||
| Q3 25 | — | $237.8M | ||
| Q2 25 | — | $240.5M | ||
| Q1 25 | — | $241.5M | ||
| Q4 24 | — | $227.2M | ||
| Q3 24 | — | $218.1M | ||
| Q2 24 | — | $225.7M | ||
| Q1 24 | — | $225.0M |
| Q4 25 | $1.2B | $-85.2M | ||
| Q3 25 | $1.3B | $-86.7M | ||
| Q2 25 | $1.4B | $-86.1M | ||
| Q1 25 | $1.5B | $-84.5M | ||
| Q4 24 | $1.5B | $-83.9M | ||
| Q3 24 | $1.6B | $-80.9M | ||
| Q2 24 | $660.5M | $-80.3M | ||
| Q1 24 | $743.9M | $-76.4M |
| Q4 25 | $1.3B | $101.1M | ||
| Q3 25 | $1.4B | $102.5M | ||
| Q2 25 | $1.5B | $104.1M | ||
| Q1 25 | $1.6B | $103.2M | ||
| Q4 24 | $1.7B | $110.6M | ||
| Q3 24 | $1.8B | $109.3M | ||
| Q2 24 | $773.1M | $107.8M | ||
| Q1 24 | $849.7M | $119.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $-23.0K |
| Free Cash FlowOCF − Capex | $-97.3M | $-481.0K |
| FCF MarginFCF / Revenue | -487.5% | -2.8% |
| Capex IntensityCapex / Revenue | 5.6% | 2.6% |
| Cash ConversionOCF / Net Profit | — | -0.02× |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | $739.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $-23.0K | ||
| Q3 25 | $-88.2M | $-296.0K | ||
| Q2 25 | $-77.1M | $5.9M | ||
| Q1 25 | $-111.5M | $-854.0K | ||
| Q4 24 | $-133.2M | $-781.0K | ||
| Q3 24 | $-84.2M | $3.4M | ||
| Q2 24 | $-72.6M | $6.8M | ||
| Q1 24 | $-99.9M | $1.9M |
| Q4 25 | $-97.3M | $-481.0K | ||
| Q3 25 | $-89.7M | $-1.3M | ||
| Q2 25 | $-78.0M | $3.6M | ||
| Q1 25 | $-112.3M | $-1.2M | ||
| Q4 24 | $-134.1M | $-1.1M | ||
| Q3 24 | $-84.6M | $3.1M | ||
| Q2 24 | $-72.7M | $2.7M | ||
| Q1 24 | $-100.0M | $1.1M |
| Q4 25 | -487.5% | -2.8% | ||
| Q3 25 | -696.5% | -7.1% | ||
| Q2 25 | -626.2% | 22.5% | ||
| Q1 25 | -1286.4% | -6.8% | ||
| Q4 24 | -1250.1% | -7.8% | ||
| Q3 24 | -944.2% | 18.3% | ||
| Q2 24 | -844.4% | 20.4% | ||
| Q1 24 | -1221.2% | 7.6% |
| Q4 25 | 5.6% | 2.6% | ||
| Q3 25 | 12.1% | 5.4% | ||
| Q2 25 | 7.0% | 13.9% | ||
| Q1 25 | 8.8% | 1.8% | ||
| Q4 24 | 9.0% | 2.4% | ||
| Q3 24 | 4.7% | 1.6% | ||
| Q2 24 | 1.8% | 30.4% | ||
| Q1 24 | 1.7% | 4.9% |
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
